Li Haichong,Yao Ziming,Guo Ruolan,et al.Genotypes and clinical intervention of patients with neurofibromatosis type 1 associated dystrophic scoliosis[J].Journal of Clinical Pediatric Surgery,2025,(04):312-319.[doi:10.3760/cma.j.cn101785-202410023-003]
Click Copy

Genotypes and clinical intervention of patients with neurofibromatosis type 1 associated dystrophic scoliosis

References:

[1] Cimino PJ,Gutmann DH.Neurofibromatosis type 1[J].Handb Clin Neurol,2018,148:799-811.DOI:10.1016/B978-0-444-64076-5.00051-X.
[2] Bianchessi D,Ibba MC,Saletti V,et al.Simultaneous detection of NF1,SPRED1,LZTR1,and NF2 gene mutations by targeted NGS in an Italian cohort of suspected NF1 patients[J].Genes (Basel),2020,11(6):671.DOI:10.3390/genes11060671.
[3] Akbarnia BA,Gabriel KR,Beckman E,et al.Prevalence of scoliosis in neurofibromatosis[J].Spine (Phila Pa 1976),1992,17(8 Suppl):S244-S248.DOI:10.1097/00007632-199208001-00005.
[4] Gutmann DH,Ferner RE,Listernick RH,et al.Neurofibromatosis type 1[J].Nat Rev Dis Primers,2017,3:17004.DOI:10.1038/nrdp.2017.4.
[5] Calvert PT,Edgar MA,Webb PJ.Scoliosis in neurofibromatosis.The natural history with and without operation[J].J Bone Joint Surg Br,1989,71(2):246-251.DOI:10.1302/0301-620X.71B2.2494186.
[6] Yao ZM,Guo D,Li H,et al.Surgical treatment of dystrophic scoliosis in neurofibromatosis type 1:outcomes and complications[J].Clin Spine Surg,2019,32(1):E50-E55.DOI:10.1097/BSD.0000000000000716.
[7] Wang ZY,Fu CF,Leng JL,et al.Treatment of dystrophic scoliosis in neurofibromatosis type 1 with one-stage posterior pedicle screw technique[J].Spine J,2015,15(4):587-595.DOI:10.1016/j.spinee.2014.10.014.
[8] Bouthors C,Dukan R,Glorion C,et al.Outcomes of growing rods in a series of early-onset scoliosis patients with neurofibromatosis type 1[J].J Neurosurg Spine,2020,33(3):373-380.DOI:10.3171/2020.2.SPINE191308.
[9] Carbone M,Vittoria F,Del Sal A.Treatment of early-onset scoliosis with growing rods in patients with neurofibromatosis-1[J].J Pediatr Orthop B,2019,28(3):278-287.DOI:10.1097/BPB.0000000000000627.
[10] Wu-Chou YH,Hung TC,Lin YT,et al.Genetic diagnosis of neurofibromatosis type 1:targeted next-generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis[J].J Biomed Sci,2018,25(1):72.DOI:10.1186/s12929-018-0474-9.
[11] Jett K,Friedman JM.Clinical and genetic aspects of neurofibromatosis 1[J].Genet Med,2010,12(1):1-11.DOI:10.1097/GIM.0b013e3181bf15e3.
[12] Kehrer-Sawatzki H,Cooper DN.Challenges in the diagnosis of neurofibromatosis type 1(NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants[J].Hum Genet,2022,141(2):177-191.DOI:10.1007/s00439-021-02410-z.
[13] Deng A,Zhang HQ,Tang MX,et al.Posterior-only surgical correction of dystrophic scoliosis in 31 patients with neurofibromatosis type 1 using the multiple anchor point method[J].J Neurosurg Pediatr,2017,19(1):96-101.DOI:10.3171/2016.7.PEDS16125.
[14] Jain VV,Berry CA,Crawford AH,et al.Growing rods are an effective fusionless method of controlling early-onset scoliosis associated with neurofibromatosis type 1(NF1):a multicenter retrospective case series[J].J Pediatr Orthop,2017,37(8):e612-e618.DOI:10.1097/BPO.0000000000000963.
[15] Tauchi R,Kawakami N,Castro MA,et al.Long-term surgical outcomes after early definitive spinal fusion for early-onset scoliosis with neurofibromatosis type 1 at mean follow-up of 14 years[J].J Pediatr Orthop,2020,40(1):42-47.DOI:10.1097/BPO.0000000000001090.
[16] Legius E,Messiaen L,Wolkenstein P,et al.Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome:an international consensus recommendation[J].Genet Med,2021,23(8):1506-1513.DOI:10.1038/s41436-021-01170-5.
[17] Langensiepen S,Semler O,Sobottke R,et al.Measuring procedures to determine the Cobb angle in idiopathic scoliosis:a systematic review[J].Eur Spine J,2013,22(11):2360-2371.DOI:10.1007/s00586-013-2693-9.
[18] Bettegowda C,Upadhayaya M,Evans DG,et al.Genotype-phenotype correlations in neurofibromatosis and their potential clinical use[J].Neurology,2021,97(7 Suppl 1):S91-S98.DOI:10.1212/WNL.0000000000012436.
[19] Pan Y,Hysinger JD,Barron T,et al.NF1 mutation drives neuronal activity-dependent initiation of optic glioma[J].Nature,2021,594(7862):277-282.DOI:10.1038/s41586-021-03580-6.
[20] van Minkelen R,van Bever Y,Kromosoeto JNR,et al.A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands[J].Clin Genet,2014,85(4):318-327.DOI:10.1111/cge.12187.
[21] Ejerskov C,Raundahl M,Gregersen PA,et al.Clinical features and disease severity in patients with mosaic neurofibromatosis type 1:a single-center study and literature review[J].Orphanet J Rare Dis,2021,16(1):180.DOI:10.1186/s13023-021-01796-3.
[22] Sabbagh A,Pasmant E,Laurendeau I,et al.Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1[J].Hum Mol Genet,2009,18(15):2768-2778.DOI:10.1093/hmg/ddp212.
[23] Harder A,Titze S,Herbst L,et al.Monozygotic twins with neurofibromatosis type 1(NF1) display differences in methylation of NF1 gene promoter elements,5’ untranslated region,exon and intron 1[J].Twin Res Hum Genet,2010,13(6):582-594.DOI:10.1375/twin.13.6.582.
[24] Zhu LD,Zhang YF,Tong HX,et al.Clinical and molecular characterization of NF1 patients:single-center experience of 32 patients from China[J].Medicine (Baltimore),2016,95(10):e3043.DOI:10.1097/MD.0000000000003043.
[25] 郭东,姚子明,高荣轩,等.生长棒与早期融合手术治疗早发性Ⅰ型神经纤维瘤病脊柱侧凸的对照研究[J].中华骨与关节外科杂志,2020,13(8):624-629.DOI:10.3969/j.issn.2095-9958.2020.08.02. Guo D,Yao ZM,Gao RX,et al.et al comparative research between growing rod and early spinal fusion surgery for early-onset scoliosis in patients with type 1 neurofibromatosis[J].Chin JBone Joint Surg,2020,13(8):624-629.DOI:10.3969/j.issn.2095-9958.2020.08.02.
[26] Sial M,George KJ.A review of spinal lesions in neurofibromatosis type 1 in a large neurofibromatosis type 1 center[J].World Neurosurg,2023,169:e157-e163.DOI:10.1016/j.wneu.2022.10.100.
[27] Toll BJ,Samdani AF,Janjua MB,et al.Perioperative complications and risk factors in neuromuscular scoliosis surgery[J].J Neurosurg Pediatr,2018,22(2):207-213.DOI:10.3171/2018.2.PEDS17724.
[28] Yao ZM,Li H,Zhang XJ,et al.Incidence and risk factors for instrumentation-related complications after scoliosis surgery in pediatric patients with NF-1[J].Spine (Phila Pa 1976),2018,43(24):1719-1724.DOI:10.1097/BRS.0000000000002720.
[29] Tritz R,Hudson FZ,Harris V,et al.MEK inhibition exerts temporal and myeloid cell-specific effects in the pathogenesis of neurofibromatosis type 1 arteriopathy[J].Sci Rep,2021,11(1):24345.DOI:10.1038/s41598-021-03750-6.
[30] Well L,Careddu A,Stark M,et al.Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI[J].Sci Rep,2021,11(1):16889.DOI:10.1038/s41598-021-96310-x.
[31] Mladenov KV,Spiro AS,Krajewski KL,et al.Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1(NF-1)[J].Childs Nerv Syst,2020,36(10):2409-2425.DOI:10.1007/s00381-020-04775-4.
[32] Li Y,Yuan XX,Sha SF,et al.Effect of higher implant density on curve correction in dystrophic thoracic scoliosis secondary to neurofibromatosis type 1[J].J Neurosurg Pediatr,2017,20(4):371-377.DOI:10.3171/2017.4.PEDS171.

Memo

收稿日期:2024-10-11。
基金项目:国家重点研发计划资助(2023YFC2507701);北京市自然科学基金-海淀原始创新联合基金资助项目(L222095)
通讯作者:张学军,Email:zhang-x-j04@163.com;郝婵娟,Email:hchjhchj@163.com

Last Update: 2025-04-28